These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2450528)

  • 21. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.
    Chaye HH; Mauracher CA; Tingle AJ; Gillam S
    J Clin Microbiol; 1992 Sep; 30(9):2323-9. PubMed ID: 1383269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chaperone-aided in vitro renaturation of an engineered E1 envelope protein for detection of anti-Rubella virus IgG antibodies.
    Scholz C; Thirault L; Schaarschmidt P; Zarnt T; Faatz E; Engel AM; Upmeier B; Bollhagen R; Eckert B; Schmid FX
    Biochemistry; 2008 Apr; 47(14):4276-87. PubMed ID: 18330994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mimicking rubella virus particles by using recombinant envelope glycoproteins and liposomes.
    Orellana A; Mottershead D; van der Linden I; Keinänen K; Oker-Blom C
    J Biotechnol; 1999 Oct; 75(2-3):209-19. PubMed ID: 10553659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of immune response to rubella virus proteins in early and late natural infections.
    Nates SV; Mersich SE; Damonte EB; Zapata MT
    Microbiologica; 1989 Oct; 12(4):335-8. PubMed ID: 2578031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary map of epitopes on envelope glycoprotein E1 of HCV strain Brescia.
    van Rijn PA; van Gennip RG; de Meijer EJ; Moormann RJ
    Vet Microbiol; 1992 Nov; 33(1-4):221-30. PubMed ID: 1282755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines.
    Petrova EK; Dmitrieva AA; Trifonova EA; Nikitin NA; Karpova OV
    Vaccine; 2016 Feb; 34(8):1006-11. PubMed ID: 26776468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of three minimal T helper cell epitopes of rubella virus E1 glycoprotein.
    Marttila J; Ilonen J; Lehtinen M; Parkkonen P; Salmi A
    Clin Exp Immunol; 1996 Jun; 104(3):394-7. PubMed ID: 9099921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome.
    Mauracher CA; Mitchell LA; Tingle AJ
    J Immunol; 1993 Aug; 151(4):2041-9. PubMed ID: 8345195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.
    van Rijn PA; van Gennip HG; de Meijer EJ; Moormann RJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2053-60. PubMed ID: 7691986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides.
    Neri P; Corti M; Lozzi L; Valensin PE
    Biopolymers; 1991 May; 31(6):631-5. PubMed ID: 1932562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.
    Seppänen H; Huhtala ML; Vaheri A; Summers MD; Oker-Blom C
    J Clin Microbiol; 1991 Sep; 29(9):1877-82. PubMed ID: 1774311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin.
    Gerna G; Revello MG; Dovis M; Petruzzelli E; Achilli G; Percivalle E; Torsellini M
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():2007-12. PubMed ID: 2439653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
    Wen H; Wang Z
    Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and characterization of a soluble rubella virus E1 envelope protein.
    Seto NO; Gillam S
    J Med Virol; 1994 Oct; 44(2):192-9. PubMed ID: 7852960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus.
    Coe NE; Mengeling WL
    Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivity of a recombinant rubella E1 antigen expressed in E. coli.
    Londesborough P; Terry G; Ho-Terry L
    Arch Virol; 1992; 122(3-4):391-7. PubMed ID: 1731700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.
    Lindqvist C; Schmidt M; Heinola J; Jaatinen R; Osterblad M; Salmi A; Keränen S; Akerman K; Oker-Blom C
    J Clin Microbiol; 1994 Sep; 32(9):2192-6. PubMed ID: 7814545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.
    Ou D; Mitchell LA; Ho M; Dćarie D; Tingle AJ; Nepom GT; Lacroix M; Zrein M
    Hum Immunol; 1994 Mar; 39(3):177-87. PubMed ID: 7517931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella virus cDNA. Sequence and expression of E1 envelope protein.
    Nakhasi HL; Meyer BC; Liu TY
    J Biol Chem; 1986 Dec; 261(35):16616-21. PubMed ID: 3023358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of immunoreactive regions of rubella virus E1 and E2 envelope proteins by using synthetic peptides.
    Mitchell LA; Décarie D; Tingle AJ; Zrein M; Lacroix M
    Virus Res; 1993 Jul; 29(1):33-57. PubMed ID: 7692685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.